Motilal Oswal remains bullish on Glenmark Pharma, citing a sharp earnings recovery, strong pipeline visibility, and improving financial metrics as key catalysts for potential upside in the stock.
Market Samachar is a news aggregator. This article was originally published by NDTV Profit - Latest. Tap the button above to read the full story on their site.